Schellens JHM - Search Results

1

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? - Authors' reply.

Henricks LM, Lunenburg CATC, Cats A, Mathijssen RHJ, Guchelaar HJ, Schellens JHM. Henricks LM, et al. Among authors: schellens jhm. Lancet Oncol. 2019 Feb;20(2):e67. doi: 10.1016/S1470-2045(19)30010-5. Lancet Oncol. 2019. PMID: 30712800 No abstract available.

2

Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.

Engwegen JY, Helgason HH, Cats A, Harris N, Bonfrer JM, Schellens JH, Beijnen JH. Engwegen JY, et al. World J Gastroenterol. 2006 Mar 14;12(10):1536-44. doi: 10.3748/wjg.v12.i10.1536. World J Gastroenterol. 2006. PMID: 16570345 Free PMC article.

3

Is rectal administration an alternative route for imatinib?

van Erp NP, Oostendorp RL, Guchelaar HJ, Schellens JH, Gelderblom H. van Erp NP, et al. Cancer Chemother Pharmacol. 2007 Sep;60(4):623-4. doi: 10.1007/s00280-006-0409-0. Epub 2007 Feb 8. Cancer Chemother Pharmacol. 2007. PMID: 17287936 Free article. No abstract available.

4

Rapid detection of the DPYD IVS14+1G>A mutation for screening patients to prevent fluorouracil-related toxicity.

Bosch TM, Bakker R, Schellens JH, Cats A, Smits PH, Beijnen JH. Bosch TM, et al. Mol Diagn Ther. 2007;11(2):105-8. doi: 10.1007/BF03256229. Mol Diagn Ther. 2007. PMID: 17397246

5

Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin.

Brouwers EE, Tibben MM, Pluim D, Rosing H, Boot H, Cats A, Schellens JH, Beijnen JH. Brouwers EE, et al. Anal Bioanal Chem. 2008 May;391(2):577-85. doi: 10.1007/s00216-008-2034-8. Epub 2008 Apr 3. Anal Bioanal Chem. 2008. PMID: 18385987

6

The Dutch vision of clinical pharmacology.

Schellens JH, Grouls R, Guchelaar HJ, Touw DJ, Rongen GA, de Boer A, Van Bortel LM. Schellens JH, et al. Clin Pharmacol Ther. 2009 Apr;85(4):366-8. doi: 10.1038/clpt.2008.148. Clin Pharmacol Ther. 2009. PMID: 19295537 Review.

7

Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk.

Engwegen JY, Depla AC, Smits ME, Cats A, Tuynman H, van Heukelem HA, Snel P, Meuleman W, Wessels LF, Schellens JH, Beijnen JH. Engwegen JY, et al. Biomark Insights. 2008 Jul 2;3:375-385. doi: 10.4137/bmi.s790. Biomark Insights. 2008. PMID: 19578519 Free PMC article.

8

Improving colorectal cancer management: the potential of proteomics.

Derijks-Engwegen JY, Cats A, Smits ME, Schellens JH, Beijnen JH. Derijks-Engwegen JY, et al. Biomark Med. 2008 Jun;2(3):253-89. doi: 10.2217/17520363.2.3.253. Biomark Med. 2008. PMID: 20477414

9

Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.

Helgason HH, Engwegen JY, Zapatka M, Vincent A, Cats A, Boot H, Beijnen JH, Schellens JH. Helgason HH, et al. Oncol Rep. 2010 Jul;24(1):57-64. doi: 10.3892/or_00000828. Oncol Rep. 2010. PMID: 20514444

10

Serum degradome markers for the detection of breast cancer.

van Winden AW, van den Broek I, Gast MC, Engwegen JY, Sparidans RW, van Dulken EJ, Depla AC, Cats A, Schellens JH, Peeters PH, Beijnen JH, van Gils CH. van Winden AW, et al. J Proteome Res. 2010 Aug 6;9(8):3781-8. doi: 10.1021/pr100395s. J Proteome Res. 2010. PMID: 20557135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

754 results

Search Page

Filters